Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 29,201Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Jakavi

PharmaCompass

01

Brand Name : Jakavi

Ruxolitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,339

2019 Revenue in Millions : 1,114

Growth (%) : 20

blank

02

Brand Name : Jakavi

Ruxolitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 1,595

2020 Revenue in Millions : 1,339

Growth (%) : 19

blank

03

Brand Name : Jakavi

Ruxolitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib

Main Therapeutic Indication : Hematology

Currency : USD

2022 Revenue in Millions : 1,561

2021 Revenue in Millions : 1,595

Growth (%) : -2

blank

04

Brand Name : Jakavi

Ruxolitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 1,720

2022 Revenue in Millions : 1,561

Growth (%) : 10

blank

05

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
Pharmtech & Ingredients
Not Confirmed

06

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib Phosphate

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 279

2014 Revenue in Millions : 410

Growth (%) : 47%

blank

07

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib Phosphate

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 581

2015 Revenue in Millions : 410

Growth (%) : 42

blank

08

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib Phosphate

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 777

2016 Revenue in Millions : 581

Growth (%) : 34

blank

09

Brand Name : Jakavi

Ruxolitinib Phosphate

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib Phosphate

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 977

2017 Revenue in Millions : 777

Growth (%) : 26%

blank

10

Brand Name : Jakavi

Ruxolitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Jakavi

arrow
Pharmtech & Ingredients
Not Confirmed

Ruxolitinib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 1,114

2018 Revenue in Millions : 977

Growth (%) : 14

blank